Mating activities in a group of 178 Barbary macaques were studied during the breeding season 1982/83. Copulations were observed between the middle of August and the end of March. More than 80% of all copulations were recorded from October to December. Number of estrous periods ranged from 1 to 5, most females (67%) had 2 estrous periods. Most females (87%) conceived during the first estrus. Postconceptional bleedings and 1 postconceptional estrus were observed regularly. Mean interval between the end of conceptional estrus and the end of postconceptional estrus was 28 days. Mean interval between the end of conceptional estrus and the onset of bleeding was 18.2 days. Conception rate was 79%. Conceptions occurred between the end of September and the middle of February. Most females (60%) conceived between the middle of November and the middle of December. Mean gestation length for a viable infant was 164.7 days. Consequences of the strong breeding seasonality are discussed.

Keywords:
Macaca sylvanus, Reproduction, Breeding season, Estrus frequency, Conception rate, Postconceptional bleedings, Postconceptional estrus, Gestation length
This content is only available via PDF.
© 1984 S. Karger AG, Basel
1984
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.